Arteris To Provide FlexGen Smart NoC IP In Next-Generation AMD AI Chiplet Designs

In a market reshaped by the compute demands of AI, Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor system IP for accelerating system-on-chip (SoC) creation, today announced AMD (Nasdaq: AMD), a global leader in high-performance and adaptive computing, has licensed FlexGen network-on-chip (NoC) interconnect IP for its next generation of AI chiplet design. FlexGen, Arteris' smart NoC IP technology, will provide high-performance data transport in AMD chiplets powering AI across the company's broad portfolio which spans from data centers to edge and end devices.

The strategic combination and interoperability of Arteris' FlexGen NoC IP with the AMD Infinity Fabric™ interconnect underscores the increasing complexity of modern SoCs and chiplet-based architectures, which now require multiple highly specialized interconnects or NoCs to efficiently meet the demands of modern electronic systems.

"We are excited to collaborate and expand our relationship with AMD, a company recognized globally for its innovation in high performance computing," said K. Charles Janac, president and CEO of Arteris. "With modern chiplets each having between 5 and 20 interconnect networks for data transport, our FlexGen NoC IP will work hand in hand with AMD's Infinity Fabric to accelerate the performance and scalability required by today's most demanding and diverse applications. This latest engagement with AMD exemplifies the transformative impact of Arteris' NoC technology in delivering next-generation silicon solutions for a wide range of markets from the data center to the edge."

"AMD is driving innovations that scale AI from cloud to client by continually developing leadership computing technologies and best-in-class IP," said Mydung Pham, corporate vice president silicon design engineering at AMD. "Integrating Arteris' FlexGen NoC IP technology into a range of AMD chiplets, we can automate interconnect configuration and enable seamless connectivity among SoC components while strengthening the best end-to-end AI compute portfolio in the industry."

Arteris is an industry leader in flexible and configurable network-on-chip IP technology. FlexGen, Arteris' latest NoC IP innovation, is specifically designed to make designing SoCs more efficient and to optimize wire length, reduce latency, and improve power efficiency, addressing the communication and performance needs of increasingly complex multi-die and chiplet-based designs. FlexGen can be utilized as an independent interconnect solution or in combination with proprietary interconnect technology to accelerate design iterations and time to market schedules.

Arteris continues to revolutionize SoC and chiplet performance with innovative technology. FlexGen smart NoC IP leverages AI automation to enhance design productivity through streamlined iteration cycles, and position companies to address the complexities of today's computing systems while dreaming up what comes next. Learn more at arteris.com/FlexGen .

About Arteris

Arteris is a global leader in system IP used in semiconductors to accelerate the creation of high-performance, power-efficient silicon. Arteris network-on-chip (NoC) interconnect IP and system-on-chip (SoC) integration automation software are used by the world's top semiconductor and technology companies to improve overall performance, engineering productivity, reduce risk, lower costs, and bring complex designs to market faster. Learn more at arteris.com .

© 2004-2025 Arteris, Inc. All rights reserved worldwide. Arteris, Arteris IP, the Arteris IP logo, and the other Arteris marks found at https://www.arteris.com/trademarks are trademarks or registered trademarks of Arteris, Inc. or its subsidiaries. All other trademarks are the property of their respective owners.

Media Contact:
Gina Jacobs
Arteris
+1 408 560 3044
newsroom@arteris.com

This press release was published by a CLEAR® Verified individual.


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

AMD
The Conversation (0)
Inmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors

Inmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced the appointment of Mr. John Bathery to its Board of Directors,... Keep Reading...
InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update

InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update

Advances INM-901 program, addressing multiple key biological pathways implicated in Alzheimer's disease pathology Further develops INM-089 demonstrating neuroprotection in the treatment of dry Age-related Macular Degeneration Cash of $11.1M to support pharmaceutical developments into the fourth... Keep Reading...
InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update

InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today reports financial results for the second quarter of the fiscal year 2025... Keep Reading...
InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration

InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration

INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the projected therapeutic level, indicating a favorable pharmacokinetic profile and a significant safety marginDose ranging studies completed InMed Pharmaceuticals Inc. (NASDAQ:... Keep Reading...
Cisco Live 2024: Cisco Announces New AI-powered Innovations and Investments to Help Customers Unlock a More Connected and Secure Future

Cisco Live 2024: Cisco Announces New AI-powered Innovations and Investments to Help Customers Unlock a More Connected and Secure Future

News summary: AI-powered innovations build customers' digital resilience by uniquely combining the power of the network with industry-leading security, observability, and data, simplifying adoption, and offering visibility and insight across the entire digital footprint. Cisco Investments has... Keep Reading...
CHARBONE annonce un financement de reglements de dettes par emission d'unites totalisant 0,5M$

CHARBONE annonce un financement de reglements de dettes par emission d'unites totalisant 0,5M$

(TheNewswire) Brossard, Quebec, le 17 octobre 2025 TheNewswire - CORPORATION CHARBONE (TSXV: CH,OTC:CHHYF; OTCQB: CHHYF; FSE: K47) (« CHARBONE » ou la « Société »), un producteur et distributeur nord-américain spécialisé dans l'hydrogène propre à Ultra Haute Pureté (« UHP ») et les gaz... Keep Reading...
CHARBONE Announces Closing of Units for Debt Financing Totaling $0.5M

CHARBONE Announces Closing of Units for Debt Financing Totaling $0.5M

(TheNewswire) Brossard, Quebec, October 17, 2025 TheNewswire - CHARBONE CORPORATION (TSXV: CH,OTC:CHHYF; OTCQB: CHHYF; FSE: K47) (" CHARBONE " or the " Company "), a North American producer and distributor specializing in clean Ultra High Purity (" UHP ") hydrogen and strategic industrial gases,... Keep Reading...
Convertible Note and Placement

Convertible Note and Placement

Carbonxt Group (CG1:AU) has announced Convertible Note and PlacementDownload the PDF here. Keep Reading...
Norway Innovation Centre for Robotics and Prototype Tank

Norway Innovation Centre for Robotics and Prototype Tank

Provaris Energy (PV1:AU) has announced Norway Innovation Centre for Robotics and Prototype TankDownload the PDF here. Keep Reading...
CHARBONE Signs Five-Year Clean UHP Hydrogen Supply Agreement in Ontario, Marking a Major Milestone in its Commercial Expansion

CHARBONE Signs Five-Year Clean UHP Hydrogen Supply Agreement in Ontario, Marking a Major Milestone in its Commercial Expansion

(TheNewswire) Brossard, Quebec TheNewswire - October 14, 2025 CHARBONE CORPORATION (TSXV: CH,OTC:CHHYF; OTCQB: CHHYF; FSE: K47) (" CHARBONE " or the " Company "), a North American producer and distributor specializing in clean Ultra High Purity (" UHP ") hydrogen and strategic industrial gases,... Keep Reading...
CHARBONE signe une entente d'approvisionnement en hydrogene propre a UHP d'une duree de 5 ans en Ontario, marquant une etape majeure dans son expansion commerciale

CHARBONE signe une entente d'approvisionnement en hydrogene propre a UHP d'une duree de 5 ans en Ontario, marquant une etape majeure dans son expansion commerciale

(TheNewswire) Brossard, Quebec TheNewswire - le 14 octobre 2025 CORPORATION CHARBONE (TSXV: CH,OTC:CHHYF; OTCQB: CHHYF; FSE: K47) (« CHARBONE » ou la « Société »), un producteur et distributeur nord-américain spécialisé dans l'hydrogène propre à Ultra Haute Pureté (« UHP ») et les gaz... Keep Reading...

Latest Press Releases

Related News